Future horizons in cardiovascular molecular therapeutics.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Cardiology

• Publication date

  1997-11-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(97)00790-XPMID 9375940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell Cycle Checkpoints

  2021cited by this paper
• Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.

  1997cited by this paper
• Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury

  1996cited by this paper
• Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor.

  1996cited by this paper
• Molecular Therapies for Vascular Diseases

  1996cited by this paper
• Induction of Apoptosis by Pyrrolidinedithiocarbamate and N-Acetylcysteine in Vascular Smooth Muscle Cells (*)

  1996cited by this paper
• Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype.

  1996cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

  1996cited by this paper
• Cell Cycle Checkpoints: Preventing an Identity Crisis

  1996cited by this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995cited by this paper
• Flow-mediated endothelial mechanotransduction.

  1995cited by this paper
• Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

  1995cited by this paper
• Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

  1995cited by this paper
• Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective.

  1995cited by this paper
• Cell biology of atherosclerosis.

  1995cited by this paper
• Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase

  1995cited by this paper
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

  1995cited by this paper
• Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers

  1995cited by this paper
• Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production.

  1995cited by this paper
• Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

  1995cited by this paper
• Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration.

  1995cited by this paper
• Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

  1995cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• Gene therapy--promise, pitfalls, and prognosis.

  1995cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Genetic engineering of vein grafts resistant to atherosclerosis.

  1995cited by this paper
• Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

  1995cited by this paper
• Electroporation of pp60c−src Antibodies Inhibits the Angiotensin II Activation of Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells (*)

  1995cited by this paper
• Evidence for apoptosis in human atherogenesis and in a rat vascular injury model.

  1995cited by this paper
• Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

  1995cited by this paper
• Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

  1995cited by this paper
• Role of oxidized LDL and antioxidants in atherosclerosis.

  1995cited by this paper
• Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril

  1995cited by this paper
• Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*)

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion

  1995cited by this paper
• Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

  1995cited by this paper
• Convergence of Angiotensin II and Platelet-derived Growth Factor Receptor Signaling Cascades in Vascular Smooth Muscle Cells (*)

  1995cited by this paper
• Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction

  1995cited by this paper
• Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

  1995cited by this paper
• Is NO an endogenous antiatherogenic molecule?

  1994cited by this paper
• Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• The emerging concept of vascular remodeling.

  1994cited by this paper
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

  1994cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper
• Meeting highlights: nitric oxide donors.

  1994cited by this paper
• Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.

  1994cited by this paper
• bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells.

  1994cited by this paper
• Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.

  1993cited by this paper
• Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.

  1993cited by this paper
• Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

  1993cited by this paper
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

  1992cited by this paper
• The pathogenesis of atherosclerosis (first of two parts).

  1976cited by this paper

• Targeted Molecular Therapeutics for Atherosclerosis

  2015cites this paper
• La apoptosis y el sistema cardiovascular

  2014cites this paper
• Erectile dysfunction in arterial hypertension

  2014cites this paper
• Die Rolle des neuentwickelten pYD-Vectors bei der Entwicklung eines Selektionssystems zum Screening von cDNA Bibliotheken auf sezernierte Proteine und Membranproteine

  2008cites this paper
• Gene 33/RALT Is Induced by Hypoxia in Cardiomyocytes, Where It Promotes Cell Death by Suppressing Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase Survival Signaling

  2006cites this paper
• Soluble adhesion molecules in inflammatory and vascular diseases.

  2005cites this paper
• The Role of Nitric Oxide in the Development of Diabetic Angiopathy

  2004cites this paper
• Erectile dysfunction is a signal of risk for significant medical comorbidities: A primary care view

  2004cites this paper
• Potential Cardiac Applications of Phosphodiesterase Type-5 Inhibition

  2004cites this paper
• Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure.

  2004cites this paper
• α-Heterosubstituted aldehydes in organic synthesis. Enantioselective approaches to new analogues of mevinic acids

  2003cites this paper
• Molecular approaches for the treatment of atherosclerosis.

  2002cites this paper
• Current approaches to therapy for vascular injury

  2001cites this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cites this paper
• Gene therapy for peripheral arterial disease.

  2000cites this paper
• A pivotal role of nitric oxide in endothelial cell dysfunction.

  2000cites this paper
• Effects of homocysteine on endothelial nitric oxide production.

  2000cites this paper
• Endothelial cell dysfunction and nitric oxide synthase.

  2000cites this paper
• Apoptosis in myocardial infarction

  2000cites this paper
• A New Transgenic Approach to an Old Problem

  1999cites this paper
• Intercellular adhesion in vascular biology, thrombosis and cancer.

  1999cites this paper
• Hypertension-induced end-organ damage : A new transgenic approach to an old problem.

  1999cites this paper